BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27855647)

  • 21. Changes in urine albumin to creatinine ratio with the initiation of hydroxyurea therapy among children and adolescents with sickle cell disease.
    Tehseen S; Joiner CH; Lane PA; Yee ME
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28612449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidative stress, antioxidant capacity, biomolecule damage, and inflammation symptoms of sickle cell disease in children.
    Biswal S; Rizwan H; Pal S; Sabnam S; Parida P; Pal A
    Hematology; 2019 Dec; 24(1):1-9. PubMed ID: 30010491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between the Lactate Dehydrogenase Levels with Laboratory Variables in the Clinical Severity of Sickle Cell Anemia in Congolese Patients.
    Mikobi TM; Lukusa Tshilobo P; Aloni MN; Mvumbi Lelo G; Akilimali PZ; Muyembe-Tamfum JJ; Race V; Matthijs G; Mbuyi Mwamba JM
    PLoS One; 2015; 10(5):e0123568. PubMed ID: 25946088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early Detection of Renal Injury in Children with Sickle Cell Anaemia using Microalbuminuria in a Tertiary Health Institution in Southern Nigeria.
    Ekpenyong EE; Ikpeme EE; Bassey EG; Dixon-Umo OT
    West Afr J Med; 2020 Sep; 37(4):412-417. PubMed ID: 32835405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of hydroxyurea therapy on intravascular hemolysis and endothelial dysfunction markers in sickle cell anemia patients.
    Chenou F; Hounkpe BW; Domingos IF; Tonassé WV; Batista THC; Santana RM; Arcanjo GDS; Alagbe AE; Araújo ADS; Lucena-Araújo AR; Bezerra MAC; Costa FF; Sonati MF; De Paula EV; Dos Santos MNN
    Ann Hematol; 2021 Nov; 100(11):2669-2676. PubMed ID: 34453189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Losartan for the nephropathy of sickle cell anemia: A phase-2, multicenter trial.
    Quinn CT; Saraf SL; Gordeuk VR; Fitzhugh CD; Creary SE; Bodas P; George A; Raj AB; Nero AC; Terrell CE; McCord L; Lane A; Ackerman HC; Yang Y; Niss O; Taylor MD; Devarajan P; Malik P
    Am J Hematol; 2017 Sep; 92(9):E520-E528. PubMed ID: 28589652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood antioxidant parameters in sickle cell anemia patients in steady state.
    Manfredini V; Lazzaretti LL; Griebeler IH; Santin AP; Brandão VD; Wagner S; Castro SM; Peralba Mdo C; Benfato MS
    J Natl Med Assoc; 2008 Aug; 100(8):897-902. PubMed ID: 18717139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature.
    Haymann JP; Stankovic K; Levy P; Avellino V; Tharaux PL; Letavernier E; Grateau G; Baud L; Girot R; Lionnet F
    Clin J Am Soc Nephrol; 2010 May; 5(5):756-61. PubMed ID: 20185605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombin generation in children with sickle cell disease: relationship with age, hemolysis, transcranial Doppler velocity, and hydroxyurea treatment.
    Noubouossie DC; Lê PQ; Rozen L; Ziereisen F; Willems D; Demulder A; Ferster A
    Eur J Haematol; 2013 Jul; 91(1):46-54. PubMed ID: 23530655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary albumin excretion is associated with pulmonary hypertension in sickle cell disease: potential role of soluble fms-like tyrosine kinase-1.
    Ataga KI; Brittain JE; Moore D; Jones SK; Hulkower B; Strayhorn D; Adam S; Redding-Lallinger R; Nachman P; Orringer EP
    Eur J Haematol; 2010 Sep; 85(3):257-63. PubMed ID: 20491879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strong association between a new marker of hemolysis and glomerulopathy in sickle cell anemia.
    Maier-Redelsperger M; Lévy P; Lionnet F; Stankovic K; Haymann JP; Lefèvre G; Avellino V; Perol JP; Girot R; Elion J
    Blood Cells Mol Dis; 2010 Dec; 45(4):289-92. PubMed ID: 20833087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antisickling property of fetal hemoglobin enhances nitric oxide bioavailability and ameliorates organ oxidative stress in transgenic-knockout sickle mice.
    Dasgupta T; Fabry ME; Kaul DK
    Am J Physiol Regul Integr Comp Physiol; 2010 Feb; 298(2):R394-402. PubMed ID: 20007516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.
    Tantawy AA; Adly AA; Ismail EA; Habeeb NM; Farouk A
    Platelets; 2013; 24(8):605-14. PubMed ID: 23249216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
    Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microalbuminuria in children with sickle cell anemia.
    Imuetinyan BA; Okoeguale MI; Egberue GO
    Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):733-8. PubMed ID: 21743219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum levels of copeptin, C-reactive protein and cortisol in different severity groups of sickle cell anaemia.
    Akinlade KS; Atere AD; Rahamon SK; Olaniyi JA
    Niger J Physiol Sci; 2013 Dec; 28(2):159-64. PubMed ID: 24937391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Energy expenditure, inflammation, and oxidative stress in steady-state adolescents with sickle cell anemia.
    Akohoue SA; Shankar S; Milne GL; Morrow J; Chen KY; Ajayi WU; Buchowski MS
    Pediatr Res; 2007 Feb; 61(2):233-8. PubMed ID: 17237728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of plasma transferrin receptor, ferritin and inflammatory markers in children with sickle cell disease.
    Al-Saqladi AW; Bin-Gadeem HA; Brabin BJ
    Paediatr Int Child Health; 2012 Feb; 32(1):27-34. PubMed ID: 22525445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased Oxidative Stress in Living Kidney Donors: Correlation of Renal Functions With Antioxidant Capacity.
    Yildirim M; Karahan M; Kucuk HF; Demir T; Demir H; Turan H; Yavuz A; Ari E
    Transplant Proc; 2017 Apr; 49(3):407-410. PubMed ID: 28340801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lactate dehydrogenase as a biomarker for early renal damage in patients with sickle cell disease.
    Alzahri MS; Mousa SA; Almomen AM; Hasanato RM; Polimeni JM; Racz MJ
    Saudi J Kidney Dis Transpl; 2015 Nov; 26(6):1161-8. PubMed ID: 26586054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.